We speculate that both p38 and JNK are essential for TGF-β1-mediated fibrosis and that the suppression of either the p38 or JNK pathway may provide a therapeutic potential to correct abnormal orbital tissue remodeling and fibrosis in GO. The gene discussed is TGFB1; the disease is geroderma osteodysplastica.